CareDx
CDNA
23 hedge funds and large institutions have $31.3M invested in CareDx in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
67% more capital invested
Capital invested by funds: $18.7M → $31.3M (+$12.6M)
5% more funds holding
Funds holding: 22 → 23 (+1)
Top Buyers
Top Sellers
| 1 |
GF
Gabelli Funds
Rye,
New York
|
-$271K |
| 2 |
Goldman Sachs
New York
|
-$115K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.69K |
| 4 |
Walleye Trading
New York
|
-$2K |
CDNA Hedge Fund Activity: Q4 2015 in Review
23 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q4 2015, worth a combined $31.3M — up 67% from $18.7M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CDNA positions and 1 closed out — a net gain of 1 holder — while 9 added to existing stakes and 3 trimmed.
The largest buyer was Paragon Associates & Paragon Associates II Joint Venture, adding an estimated $1.93M. The largest seller was Gabelli Funds, cutting an estimated $271K.
- 23 institutional investors held CareDx (CDNA) as of Q4 2015, up from 22 in Q3 2015.
- Funds reported $31.3M of CareDx stock for Q4 2015, up 67% quarter-over-quarter.
- 2 funds opened new CareDx positions in Q4 2015 and 1 closed out, a net change of +1 holder.
- The largest CareDx buyer in Q4 2015 was Paragon Associates & Paragon Associates II Joint Venture, an estimated $1.93M added.
- The largest CareDx seller in Q4 2015 was Gabelli Funds, an estimated $271K sold.
Based on aggregated 13F filings for Q4 2015.